FDA Adverse Event Malfunction Summary report: N

ENDOTAK RELIANCE

MDR report key: 3951052 · Received July 22, 2014

Report

Report Number
2124215-2014-11257
Event Type
Malfunction
Date Received
July 22, 2014
Date of Event
September 30, 2013
Report Date
November 1, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, IT WAS NOTED THAT THE LEAD WAS SEVERED 81 AND 249 MILLIMETERS (MM) FROM THE TERMINAL PIN. A TOTAL OF THREE SEGMENTS WERE RETURNED. VISUAL ANALYSIS REVEALED INSULATION DAMAGE THAT WENT THROUGH ALL FOUR LAYERS OF THE INSULATION, THROUGH TO THE RATE/SENSE CONDUCTOR COIL 60-67 MILLIMETERS FROM THE TERMINAL PIN. THE ABRADED REGION OF THE LEAD WOULD HAVE BEEN LOCATED WITHIN THE POCKET AREA. DUE TO THE LOCATION AND TYPE OF DAMAGE, IT WAS LIKELY CAUSED BY LEAD-ON-CAN CONTACT COUPLED WITH MOVEMENT AND PRESSURE. SURFACE ABRASIONS WERE NOTED ON THE TERMINAL BOOT AREA AS WELL; ONE WAS IN LINE WITH THE ABRASION (CONTINUING LEAD-ON-CAN) AND ONE WAS ADJACENT TO THE ABRASION (MOST LIKELY LEAD-ON-LEAD). LABORATORY ANALYSIS CONFIRMED THE FIELD ALLEGATION AND THAT PACING THERAPY WOULD HAVE BEEN COMPROMISED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS RIGHT VENTRICULAR (RV) LEAD EXHIBITED NOISE. THE NOISE WAS OVERSENSED WHICH RESULTED TO INAPPROPRIATE ANTI-TACHYCARDIA PACING (ATP). THIS RV LEAD WAS EXPLANTED AND WAS SUCCESSFULLY REPLACED. DURING THE REVISION PROCEDURE, A LEAD INSULATION ISSUE WAS SEEN AND THE PHYSICIAN BELIEVED IT WAS DUE TO LEAD-TO-CAN ISSUE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
427913 ENDOTAK RELIANCE NVY CPI - DEL CARIBE 0296

Patients

Seq Age Sex Outcome Treatment
1 MISMATCH| 0693| 0296| 4096| 4555| P142| 4543